Open-Label, Single-Center, Single Dose Positron Emission Topography (PET) Using [11C]PBR28 to Evaluate Brain Translocator Protein 18KDa (TSPO) Occupancy of ONO-2952 in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 31 May 2013
At a glance
- Drugs ONO 2952 (Primary)
- Indications Irritable bowel syndrome
- Focus Pharmacokinetics
- 01 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Aug 2012 Actual initiation date (Aug 2012) added as reported by ClinicalTrials.gov.
- 01 Aug 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.